Group of Cyclists Riding Through Rain
July 28, 2022
C2C4C: back on the road and bigger than ever >
Robert A Winn Pathway Program
July 19, 2022
The future of diversity in clinical trials >
Clasped hands
June 16, 2022
Juneteenth: Remembering the past, reimagining the future >
Lupus: Treatments, Research and Bristol Myers Squibb’s Dedication to Patients – A Q&A with Subhashis Banerjee
May 27, 2022
Lupus: Treatments, research and Bristol Myers Squibb’s dedication to patients – A Q&A With Subhashis Banerjee >
Bristol Myers Squibb facility in Moreton, UK, exemplifies sustainability innovation
April 21, 2022
R&D facility building in the UK exemplifies sustainability innovation >
Consumer wearable technology advancements may support AFib detection
April 15, 2022
Consumer wearable technology advancements may support AFib detection >
COLORS Training Program
April 11, 2022
COLORS training program spreads education of healthcare needs in the LGBTQ+ community >
Bristol Myers Squibb scientists Kim Harrington (left) and Ruth Salmon
April 04, 2022
Give and take: The power of mentorship at Bristol Myers Squibb >
Bristol Myers Squibb Cancer Support Network
March 24, 2022
‘We take care of our BMS family’ – Bristol Myers Squibb Cancer Support Network >
Early development center to open in Cambridge Crossing
March 03, 2022
New state-of-the-art research and early development center to open in Cambridge Crossing >
Bristol Myers Squibb’s Thomas O. Daniel Research Incubator and Collaboration Center
February 14, 2022
Unleashing innovation through incubators and beyond >
Adam Lenkowsky, senior vice president and general manager of U.S. Cardiovascular, Immunology and Oncology, Bristol Myers Squibb
February 07, 2022
Advancing our commitment to health equity  >